Technology
FairJourney Bio Consolidates Antibody Discovery Data with the Sapio Sciences Scientific AI Platform
Published
1 hour agoon
By
Leading Antibody Discovery Expert Standardizes on the Sapio Scientific AI Platform to Accelerate Delivery for Biotechnology Clients
The Sapio Scientific AI Platform will serve as the informatics backbone across FJBio’s discovery and cell sciences operations, spanning sites in Cambridge, Porto and San Diego.Sapio Sciences’ ELN and LIMS solutions will replace disconnected, paper-based data capture and manual reporting processes across phage display, screening and cell sciences programs.Users will gain an AI co-scientist, Elain to expedite efficiency while file-based integration of 10 laboratory instruments will output directly to Sapio experiment records.
BALTIMORE, Sept. 14, 2026 /PRNewswire/ — Sapio Sciences, the AI lab informatics company, today announced that FairJourney Bio (FJBio), an antibody discovery expert, has selected the Sapio Scientific AI Platform, including Sapio’s LIMS, ELN and AI co-scientist solutions to replace spreadsheet-based records and manual reporting processes across its international operations.
FJBio is a global antibody discovery and engineering partner. Founded in 2012, the Company takes programs from target to preclinical candidate within a single integrated workflow, run by one team across three centers of excellence: Porto (Portugal), Cambridge (UK) and San Diego (USA). The antibody company completed more than 1,400 programs for over 250 industry partners across pharma, biotech, and academia, with 20 partner assets in clinical trials.
Unifying Informatics Across Connected Discovery Operations
The volume and complexity of experimental data generated across those programs made consistent, structured records a scientific and operational priority for FJBio. The Sapio Scientific AI Platform will serve as the informatics backbone across all of FJBio’s discovery and cell sciences operations.
Sapio’s ELN solution will record experimental data across phage display, screening and cell sciences programs, replacing the need for scientists to capture data on paper templates before manually re-entering results into spreadsheets. As FJBio’s program portfolio has grown across three sites, the Sapio LIMS gives the company a single entity registry, from target registration through clone identification and screening results, searchable across programs.
The solution will also ensure integration of laboratory instruments, connecting instrument output directly to Sapio’s experiment records and eliminating manual data transcription at the bench. FJBio clients will now get more scientist time on their programs and their data sooner. Structured client data reports, that were assembled by hand from individual experiment records will now come straight out of the platform, expected to return up to 40% of scientific staff time back to discovery.
Mike Hampton, Chief Commercial Officer at Sapio Sciences, commented, “FairJourney Bio runs discovery programs of genuine depth and complexity across multiple international sites. The Sapio Scientific AI Platform gives their scientists a single, structured environment where experimental records connect directly to client deliverables and where time spent on data consolidation becomes time spent on science.”
Strategic Foundation for Scalable Antibody Discovery
FJBio selected the Sapio Scientific AI Platform following a strategic review of its informatics infrastructure. For an antibody discovery expert managing high-complexity discovery programs across three international sites, the ability to configure a single environment spanning both ELN and LIMS capabilities, without fragmentation across separate systems, was a core requirement.
The depth of Sapio’s Scientific AI Platform data model, and its ability to support full traceability from target registration through screening and hit identification, provided the technical foundation FJBio needed. The inclusion Elain, Sapio’s native AI co-scientist, rather than a bolt-on capability, was a further differentiator as FJBio looks to build long-term informatics capability alongside its expanding discovery operations.
José Vidal, Chief Operations Officer at FairJourney Bio, commented, “Our clients trust FairJourney Bio to deliver rigorous, high-quality data at every stage of their discovery programs. As our operations have grown across three international sites, we needed an informatics platform that could keep pace with that responsibility. The Sapio Platform gives our scientists a single connected environment for every experiment, every sample and every result, and it holds that data to the integrity and security standards our clients expect: consistent, traceable and unaltered from the moment it is generated, and held under the access controls each program requires.”
Advancing Productivity with AI Capabilities
Elain, Sapio’s native AI co-scientist, brings intelligence directly into FJBio’s scientific workflows. Working across the structured experimental data held within the Sapio Platform, Elain enables scientists to interact with their data using natural language, without leaving the environment where their experiments, samples and results are managed.
Elain is designed to help scientists understand, reason and act. It can find and summarize information across experimental records, analyze scientific data and surface relevant insights. It can then help scientists act on those insights by generating reports, supporting workflow execution and automating repetitive tasks. For FJBio, this creates the potential to reduce time spent searching for information, consolidating results and preparing client deliverables, giving its scientists more time to focus on advancing antibody discovery programs.
About FairJourney Bio
FairJourney Bio (FJBio), The Antibody Company, is a global antibody discovery and engineering partner. Founded in 2012, the Company takes programs from target to preclinical candidate within a single integrated workflow, run by one team across three centers of excellence: Porto (Portugal),; Cambridge (UK); and San Diego (USA).
FJBio has completed more than 1,400 programs for over 250 industry partners across pharma, biotech, and academia, with 20 partner assets in clinical trials. Its team of more than 250 scientists, including over 60 PhDs in mAb antibody research, designs developability into each molecule from the first sequence, delivering advanceable leads rather than hits that still need fixing.
In 2024, Partners Group, one of the largest firms in the global private markets industry, invested in FJBio and supported the start of its US expansion. The Company has since built a dedicated structural biology hub in San Diego, including in-house 300kV cryo-EM, to advance structure-guided antibody design under EU and US intellectual property and regulatory frameworks.
For more information, please visit: www.fjbio.com/
About Sapio Sciences
Sapio Sciences delivers the Sapio Platform, an agentic AI lab informatics platform for biopharma R&D, clinical diagnostics and manufacturing. Built on a shared foundation, the Sapio Platform unifies Sapio LIMS and Sapio ELN in one configurable environment, with Sapio Elain, the AI co-scientist, orchestrating intelligence across every workflow. Learn more at www.sapiosciences.com and follow Sapio Sciences on LinkedIn.
Media Inquiries
Dayna Carlin
410.800.4620
422545@email4pr.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/fairjourney-bio-consolidates-antibody-discovery-data-with-the-sapio-sciences-scientific-ai-platform-302877575.html
SOURCE Sapio Sciences
You may like
Technology
Knak Expands Its AI Production Layer to Mobile as RCS Business Use Grows
Published
1 second agoon
September 14, 2026By
Enterprise demand for marketing production increases as brands look to add more channels and strengthen marketing performance.
SAN FRANCISCO, Sept. 14, 2026 /PRNewswire/ — Knak, the AI production layer for enterprise marketing, today launched Mobile Message Builder, bringing SMS and Rich Communication Services (RCS) message production into the same production environment where teams build email and landing pages.
For more information on Knak’s mobile message builder, visit knak.com/mobile.
Marketing production is the system between creative brief and send, where campaign assets get built, personalized, optimized, and approved. AI has made drafting content nearly free. The work that goes into producing the finished, on-brand, approved asset hasn’t kept pace. Knak’s “Marketing Production in the Age of AI” study of 333 enterprise marketers found 85% missed at least one planned campaign launch last year because of production constraints, with approvals, creative production and cross-team coordination the leading causes.
That production gap is showing up fast in the newest marketing channel. RCS asks marketing teams to build richer, interactive content and clear carrier and brand-verification approvals, on top of the campaign workflows they already run. Most of that work happens outside any production system — in docs, spreadsheets and whichever sending platform’s editor is closest to hand — with no shared brand rules, no version history and no approval trail. Juniper Research forecasts that business RCS messages will nearly quadruple, from 125 billion globally in 2026 to more than 485 billion by 2030.
Mobile Message Builder puts SMS and RCS on the same production line, with the same brand standards, collaboration and approval workflows teams already use for every other asset they ship.
“Mobile is the channel customers open first, and it’s usually the one with the least production rigor behind it. Teams spent years building approval chains and brand control into email. Mobile never got that treatment, and RCS is making that hard to ignore,” said Brendan Farnand, co-founder and CCO at Knak. “Adding a channel shouldn’t mean adding another process and another tool. A text should clear the same review as everything else you ship.”
Mobile Message Builder is built into Knak and includes:
One production line across channels: Build SMS and RCS in the same environment as email and landing pages, on shared assets, brand guidelines and design rules, so a campaign holds together across every channel it runs on.RCS and its SMS fallback in one asset: Create both versions together, with AI generating the SMS variant from the RCS message, and keep them together through review and approval instead of tracking them separately.Preview before export: See personalized messages in light and dark mode with merge tags resolved, so rendering problems get caught before execution rather than after.Governance built in: Comment, tag colleagues, run multi-step approvals, and keep version history and a full audit trail — alongside brand voice checks and mobile-specific requirements like character limits, required opt-out language and RCS fields.
“When email, SMS and RCS are built for the same journey, they need to be reviewed in the same place,” said Felipe Giannazzo, Manager, Product Technology – MarTech at AT&T. “We have to prove an SMS or RCS message will render the way creative intended before it goes to execution, and that usually means test sends and manual validation across a pile of devices. Having that content sit alongside our email pipeline in Knak takes the manual work out of it.”
Mobile messaging is the third channel on Knak’s production line, with more planned in 2027.
Knak will show Mobile Message Builder at Dreamforce, Sept. 15–17, 2026, at Moscone Center in San Francisco, alongside its roadmap for enterprise AI marketing production across email, landing pages, mobile messaging and advertising.
Mobile Message Builder is in beta with enterprise customers now and will be generally available in October 2026.
About Knak
Knak is the AI production layer for enterprise marketing – the system between creative brief and send, where your team and AI build on-brand campaigns that are more personalized, more tested, and live in days. Trusted by Google, Amazon, Uber, Meta, OpenAI, Forbes, and Palo Alto Networks.
Media Contact
PANBlast for Knak
Jaclyn Westlake
jwestlake@panblastpr.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/knak-expands-its-ai-production-layer-to-mobile-as-rcs-business-use-grows-302877091.html
SOURCE Knak
Technology
Pipette Calibration Services Market worth $834.8 million by 2031 – Exclusive Report by MarketsandMarkets™
Published
4 seconds agoon
September 14, 2026By
DELRAY BEACH, Fla., Sept. 14, 2026 /PRNewswire/ — According to MarketsandMarkets™, the pipette calibration services market is projected to reach USD 834.8 million by 2031 from USD 383.2 million in 2026, at a CAGR of 16.9% from 2026–2031. The pipette calibration services market is driven by the increasing adoption of precision laboratory practices to ensure measurement accuracy, regulatory compliance, and reliable experimental outcomes. Growing demand from pharmaceutical and biotechnology companies, clinical and diagnostic laboratories, and research institutions, coupled with rising laboratory automation and stringent quality standards, is accelerating market growth.
Browse 350 market data Tables and 50 Figures spread through 450 Pages and in-depth TOC on ” Pipette Calibration Services Market – Global Forecast to 2031″
Pipette Calibration Services Market Size & Forecast:
Market Size Available for Years: 2026–20312026 Market Size: USD 383.2 million2031 Projected Market Size: USD 834.8 millionCAGR (2026–2031): 16.9%
Pipette Calibration Services Market Trends & Insights:
The North American region dominated the pipette calibration services market, with a share of 50.6% in 2025.By service type, hybrid programs segment is expected to register the highest CAGR of 17.7% during the forecast period.By service provider, the OEM/manufacturer-affiliated segment dominated the market in 2025.By instrument, the electronic/motorized segment is expected to register the highest CAGR during the forecast period.By end user, the CRO/CDMO segment is expected to register the highest CAGR during the forecast period.Eppendorf SE, Sartorius AG, and Thermo Fisher Scientific Inc. were identified as some of the star players in the pipette calibration services market (global), given their strong market share and footprint.Accredited Labs and Dlab Scientific, Co. Ltd., among others, have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas, underscoring their potential as emerging market leaders.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=144210658
Based on service type, the pipette calibration services market is segmented into on-site calibration, off-site calibration, and hybrid programs. The on-site calibration segment accounted for the largest market share in 2025, owing to its ability to minimize instrument downtime, eliminate transportation requirements, and maintain laboratory workflows during calibration activities. Pharmaceutical and biotechnology companies, clinical and diagnostic laboratories, research institutions, and testing laboratories increasingly prefer on-site services for calibrating large pipette inventories directly at their facilities. These services enable technicians to perform calibration, performance verification, adjustment, and preventive maintenance without requiring instruments to be shipped to external laboratories. Furthermore, the increasing adoption of high-throughput and automated liquid-handling systems is strengthening demand for rapid and convenient calibration solutions. The availability of accredited on-site calibration services, flexible scheduling, multi-brand servicing, and integrated maintenance programs is further supporting the segment’s market leadership.
Based on service provider type, the pipette calibration services market is segmented into OEM/manufacturer-affiliated, independent third-party metrology labs, and distributor-led service networks. The independent third-party metrology labs segment is expected to register the highest CAGR during the forecast period, owing to the growing preference for multi-brand calibration services, greater flexibility in service selection, and increasing demand for accredited and traceable calibration from specialized providers. Independent laboratories can service pipettes from multiple manufacturers, enabling pharmaceutical and biotechnology companies, clinical laboratories, research institutions, and testing facilities to consolidate calibration activities with a single service provider. Their ability to offer ISO/IEC 17025-accredited calibration, on-site and off-site services, repair and maintenance, faster turnaround, and customized service programs is further strengthening their appeal. Additionally, the expansion of large laboratory networks and increasing adoption of outsourced equipment maintenance are encouraging organizations to rely on independent metrology specialists rather than manufacturer-specific service channels. These advantages, combined with growing demand for cost-effective and flexible calibration solutions, are expected to accelerate the adoption of independent third-party metrology labs throughout the forecast period.
Inquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=144210658
North America was the largest market for pipette calibration services globally in 2025. This leadership position is attributed to the region’s well-established pharmaceutical and biotechnology industries, extensive clinical and life sciences research infrastructure, stringent laboratory quality requirements, and strong adoption of accredited calibration practices. The region is home to several major companies providing pipette calibration, maintenance, and laboratory equipment services, including Thermo Fisher Scientific, Eppendorf, and Sartorius. These companies and specialized calibration providers support pharmaceutical manufacturers, biotechnology companies, academic institutions, clinical laboratories, and research organizations across the region. The US also has a large and sophisticated laboratory ecosystem supported by substantial federal investment in biomedical research and pharmaceutical development. In addition, requirements for laboratory equipment qualification, measurement accuracy, preventive maintenance, and traceability are encouraging organizations to adopt periodic pipette calibration and certification services. The growing presence of ISO/IEC 17025-accredited calibration laboratories and increasing demand for on-site calibration services further support the expansion of the North America pipette calibration services market.
Key Players
Leading players in the pipette calibration services companies include Eppendorf SE (Germany), Sartorius AG (Germany), METTLER TOLEDO (US), Thermo Fisher Scientific Inc. (US), Transcat, Inc. (US), and Trescal SAS (France), among others. These companies adopted strategies such as product launches, expansions, agreements, partnerships, collaborations, and acquisitions to strengthen their market presence in the pipette calibration services market.
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=144210658
Investment & funding +Merger & Acquisition
Investment Funding Context
The pipette calibration services market is witnessing increasing investment activity, primarily through strategic acquisitions, expansion of accredited calibration networks, and investments in specialized laboratory service capabilities. In August 2025, Transcat acquired Essco Calibration Laboratory for USD 84 million in cash, marking the largest acquisition in Transcat’s history; Essco generated more than USD 22 million in annual revenue and provided in-house and on-site calibration services to medical and life sciences customers, while the transaction was supported by a newly established USD 150 million syndicated credit facility led by M&T Bank and Wells Fargo. In December 2024, Transcat acquired Martin Calibration Inc. for USD 79 million, comprising USD 69 million in cash and USD 10 million in Transcat stock, strengthening its ISO 17025-accredited calibration laboratory network serving medical and life sciences sectors. Furthermore, in April 2026, Transcat acquired SCM Metrology and Laboratories S.A., expanding its calibration-services footprint into Costa Rica and Latin America. These developments indicate growing strategic investment in calibration infrastructure, geographic expansion, and specialized metrology capabilities, with continued activity expected around laboratory-network consolidation, on-site service expansion, digital calibration management, and specialized liquid-handling capabilities.
Revenue Shift Context
The pipette calibration services market is witnessing a gradual shift from conventional, periodic calibration toward more comprehensive, technology-enabled, and lifecycle-oriented service models. automated performance verification, and predictive maintenance. Meanwhile, traditional off-site calibration remains an important service model, particularly for laboratories requiring accredited testing and specialized equipment; however, on-site and hybrid services are capturing a rising share of new demand as pharmaceutical, biotechnology, clinical, and research laboratories prioritize reduced downtime, faster turnaround, equipment traceability, and flexible calibration scheduling. The increasing adoption of electronic/motorized and automated pipettes is further supporting demand for specialized calibration and service capabilities, while digital records, automated scheduling, and integrated maintenance programs are gradually transforming the market from standalone calibration toward connected equipment lifecycle management.
Mergers and Acquisitions
Mergers/acquisitions in the pipette calibration services market are expected to increase during 2025–2026, driven by growing consolidation among calibration and metrology service providers. Buyers are increasingly prioritizing accredited service capabilities, broader geographic coverage, specialized laboratory expertise, and integrated calibration and maintenance portfolios as demand for reliable, traceable laboratory services expands.
PIPETTE CALIBRATION SERVICES MARKET: MERGERS AND ACQUISITIONS, JANUARY 2025–AUGUST 2026
Month & Year
Deal Type
Company 1
Company 2
Description
April 2026
Acquisition
Transcat, Inc. (US)
SCM Metrology and Laboratories S.A. (Costa Rica)
Transcat acquired SCM Metrology to expand its calibration and metrology services into Latin America, strengthening its international service footprint.
December 2025
Acquisition
Medical Technology Associates (MTA) (US)
Florida Pipette Calibration LLC (US)
Medical Technology Associates acquired Florida Pipette Calibration LLC to expand its specialized pipette calibration and repair capabilities and strengthen its laboratory service offerings for medical, scientific, and research facilities.
August 2025
Acquisition
Transcat, Inc. (US)
Essco Calibration Laboratory (US)
Transcat acquired Essco Calibration Laboratory for USD 84 million to expand its accredited calibration capabilities and strengthen its presence across medical, life sciences, and industrial markets.
Company Revenue Share Details
The total market share of the top three players is estimated at 15–25%, indicating a fragmented pipette calibration services market with significant competition among established service providers and laboratory equipment companies. This level of fragmentation suggests that no single company has dominant control of the market, leaving considerable opportunities for expansion and consolidation. The top three players, Eppendorf SE, Sartorius AG, and Thermo Fisher Scientific Inc., have strong positions supported by established laboratory equipment portfolios, technical expertise, customer relationships, and global service capabilities. The presence of multiple players with varying service offerings further reflects the competitive nature of the market and creates opportunities for companies to strengthen their positions through service expansion, geographic reach, calibration capabilities, and strategic acquisitions.
Browse Adjacent Market: Analytical and Scientific Instrumentation Market Research Reports &Consulting
See Latest Analytical and Scientific Instrumentation Market Reports:
Pipette Calibrators Market by Type (Devices, Software), Channel Type, Method (Gravimetry, Photometry), Application (Research (Drug Discovery), Clinical Diagnostics), End User (Pharmaceutical & Biotechnology), & Region – Global Forecast to 2029
Diagnostic Electrocardiograph Market by Product (Resting ECG, Stress ECG, Mobile Cardiac Telemetry), Lead Type (Single-lead, 3, 5, 6 & 12-lead ECG Device), Type (Portable ECG Device, Wearable ECG Device), Connectivity – Global Forecast to 2032
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America’s Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the ‘GIVE Growth’ principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
MarketsandMarkets™ SalesPlay is an AI-driven Revenue Intelligence Co-Pilot designed to help revenue teams prioritize the right accounts, identify critical changes early, and surface opportunities ahead of demand, so pipeline builds naturally and deals close with greater consistency.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/pipette-calibration-services-companies.asp
Content Source: https://www.marketsandmarkets.com/PressReleases/pipette-calibration-services.asp
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/pipette-calibration-services-market-worth-834-8-million-by-2031—exclusive-report-by-marketsandmarkets-302877411.html
Technology
Closer Launches in Alberta with Conveyancing Software Built for Western Closings
Published
10 seconds agoon
September 14, 2026By
LONDON, ON, Sept. 14, 2026 /CNW/ — Closer, the conveyancing platform used by over 600 real estate law firms across Ontario, today announced its general availability to law firms in Alberta. The launch follows a 3-month early access program with 14 firms in Calgary, Edmonton, and across Alberta.
For years, conveyancing technology has suffered from stagnation, leaving legal professionals to rely on legacy software that fails to adapt to modern operational pressures. Closer enters Alberta as a direct response to a market underserved by existing platforms, offering a purpose-built alternative that streamlines property transactions and eliminates workflow bottlenecks.
Built for Alberta practice
Protocol matter workflow. Matters follow Western Law Societies’ Conveyancing Protocol closings, with the required documents and undertakings built in.Alberta precedent library. Hundreds of documents drafted for Alberta practice, including Transfers of Land, Affidavits of Value, and Dower Affidavits.Client-facing intake. Buyers and sellers submit details and documents through a secure portal that populates matters automatically and is included at no extra cost.Digital identity verification. Treefort and FCT Client ID Verification integrations supporting client identification and fraud reduction.In-platform Alberta title searches. Title and plan searches run through SPIN2 without leaving the matter, with support for ARLO as it becomes the system of record.Lender and mortgage instruction processing. Digital handling of mortgage instructions from major Canadian lenders through FCT’s Lender Lawyer Connect and Sync included at no extra charge.Title insurance ordering in-platform. Integrations with FCT, Stewart Title, and Chicago Title.Integrated e-signing: Built-in DocuSign with SignIT for all standard real estate documents, allowing clients to sign remotely with zero transaction or add-on fees.Alberta-based onboarding and support. Paralegals and product specialists based in Alberta, available 8:00 a.m. to 6:00 p.m. MT, backed by industry-leading 11-second response time and 99% client satisfaction rate.
“The transition to ARLO signals a new era of digital transformation for Alberta conveyancers. We’re excited to introduce Closer to the market at a time when firms are ready for real innovation. It represents the modern standard for property transactions, far surpassing what legacy platforms or basic software can offer.” said Harrison Kelly, CEO of Closer. “We designed Closer for Alberta to provide law firms with a modern, high-performance conveyancing solution without the heavy financial markup.”
Availability
Closer is available for Alberta firms today with exclusive early-adopter pricing for the first 6 months. Book a demonstration here.
About Closer
Closer is a conveyancing software platform for Canadian real estate law firms, supporting residential purchase, sale, refinance and transfer matters from intake through final report. Closer connects firms to title insurers, lenders, land registries, and identity verification providers in a single workflow, and is used by over 600 firms across Ontario and Alberta. Visit our website here to learn more.
Website: www.closer.ca
SOURCE Closer
Knak Expands Its AI Production Layer to Mobile as RCS Business Use Grows
Pipette Calibration Services Market worth $834.8 million by 2031 – Exclusive Report by MarketsandMarkets™
Closer Launches in Alberta with Conveyancing Software Built for Western Closings
Send Rakhi to UK swiftly with UK Gifts Portal
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
New Gooseneck Omni Antennas Offer Enhanced Signals in a Durable Package
Why You Should Build on #NEAR – Co-founder Illia Polosukhin at CV Labs
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
NEAR End of Year Town Hall 2021: The Open Web World, MetaBUILD 2 Hackathon and 2021 recap
Trending
-
Technology5 days agoCloudphysician Unveils Nightingale, a Visual Intelligence Foundation Model Built for the Hospital Room
-
Technology5 days agoMarketPlace PHL Selects Watchfire to Modernize Concessions Communications
-
Technology5 days agoENVESTNET TO ACQUIRE VESTMARK, EXTENDING ITS CAPABILITIES TO MEET THE ADVISOR MARKET’S GROWING DEMAND FOR INCREASINGLY SOPHISTICATED TRADING AND TAX SOLUTIONS
-
Technology5 days agoColorado Imaging Associates and TRA Medical Imaging Launch Affiliated Radiology
-
Technology5 days agoAI Is Changing How Consumers Find Local Businesses — Is Your Business Being Recommended?
-
Technology5 days agoNutrient Data Extraction API launches for source-grounded, production-ready document AI
-
Technology5 days agoNonco Expands Institutional Collateral Toolkit from Tokenized Money Market Funds to Secured Sovereign Debt
-
Technology5 days agoARPA-H Selects UpDoc to Lead Development of Autonomous Clinical AI System, in an Initiative Joined by Microsoft, OpenAI and NVIDIA
